U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H11N.ClH
Molecular Weight 157.641
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2,6-XYLIDINE HYDROCHLORIDE

SMILES

Cl.CC1=CC=CC(C)=C1N

InChI

InChIKey=QNWMFJDRMZWZNN-UHFFFAOYSA-N
InChI=1S/C8H11N.ClH/c1-6-4-3-5-7(2)8(6)9;/h3-5H,9H2,1-2H3;1H

HIDE SMILES / InChI

Molecular Formula C8H11N
Molecular Weight 121.1796
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
HPLC-DAD stability indicating determination of nitrofurazone and lidocaine hydrochloride in their combined topical dosage form.
2010-09
Investigating the mechanisms of aromatic amine-induced protein free radical formation by quantitative structure-activity relationships: implications for drug-induced agranulocytosis.
2010-05-17
Third-order nonlinear optical properties and structures of (E)-N-(4-nitrobenzylidene)-2,6-dimethylaniline and (E)-N-(4-nitrobenzylidene)-2,3-dimethylaniline.
2010-05
N-(2,6-Dimethyl-phen-yl)-4-methyl-benzene-sulfonamide.
2010-04-24
Chemical oxidation of 2,6-dimethylaniline by electrochemically generated Fenton's reagent.
2010-04-15
N-(2,6-Dimethyl-phen-yl)succinimide.
2010-01-09
Monocyclic aromatic amines as potential human carcinogens: old is new again.
2010-01
Kinetics and mechanism of 2,6-dimethyl-aniline degradation by hydroxyl radicals.
2009-12-30
N-(2,6-Dimethyl-phen-yl)-2-(2-thien-yl)acetamide.
2009-11-25
Chemical oxidation of 2,6-dimethylaniline in the fenton process.
2009-11-15
Iron-catalyzed dehydrogenative phosphonation of N,N-dimethylanilines.
2009-10-28
N-(2,6-Dimethyl-phen-yl)maleamic acid.
2009-10-23
Separation and analysis of dimethylaniline isomers by supercritical fluid chromatography--electrospray ionization tandem mass spectrometry.
2009-10-09
Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques.
2009-09
N-[3-(2,6-Dimethylanilino)-1-methylbut-2-enylidene]-2,6-dimethylanilinium chloride.
2009-06-24
Ethyl 2-[(2,6-dimethyl-phen-yl)hydrazono]-3-oxobutanoate.
2009-06-10
Mixed carbene-isocyanide Pd(II) complexes: synthesis, structures and reactivity towards nucleophiles.
2009-03-28
N-(2,6-Dimethyl-phen-yl)succinamic acid.
2009-02-06
Kinetics of 2,6-dimethylaniline degradation by electro-Fenton process.
2009-01-30
The importance of CH/pi hydrogen bonds in rational drug design: An ab initio fragment molecular orbital study to leukocyte-specific protein tyrosine (LCK) kinase.
2008-12-15
2,6-Dimethyl-anilinium chloride monohydrate.
2008-11-29
N-(2,6-Dimethyl-phen-yl)benzene-sulfonamide.
2008-08-06
Assessment of the medicines lidocaine, prilocaine, and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues.
2008-08
Quantitative mass spectrometric analysis of ropivacaine and bupivacaine in authentic, pharmaceutical and spiked human plasma without chromatographic separation.
2008-05-28
N-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-ylcarbon-yl)-N'-(2,6-dimethyl-phen-yl)thio-urea.
2007-12-06
Temperature investigations of E/Z isomers in ketimines based of p-dibenzoylobenzene with aniline and 2,6-dimethylaniline by infrared spectroscopy.
2007-10
Expedient syntheses of the N-heterocyclic carbene precursor imidazolium salts IPr.HCl, IMes.HCl and IXy.HCl.
2007-08-28
Liquid-phase microextraction-gas chromatography-mass spectrometry for the determination of bromate, iodate, bromide and iodide in high-chloride matrix.
2007-05-04
Similarities and differences between azomethines and ketimines: synthesis, materials characterization and structure of novel imines compounds.
2007-04
In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations.
2007-01
Pi-Pi complexation of bupivacaine and analogues with aromatic receptors: implications for overdose remediation.
2007
Amine mediated proton transfer reaction and C-Cl bond activation of solvent chloroform by a trinuclear copper(II) complex of a glucopyranosylamine derived ligand.
2006-08-21
DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice.
2006-08
Production and characterization of laccase from Cyathus bulleri and its use in decolourization of recalcitrant textile dyes.
2006-08
Synthesis, structure, and characterization of molybdenum(VI) imido complexes with N-salicylidene-2-aminophenol.
2006-07-10
Changes in production of lignin degrading enzymes during interactions between mycelia of the tropical decomposer basidiomycetes Marasmiellus troyanus and Marasmius pallescens.
2006-02
Regioselective copper-catalyzed amination of chlorobenzoic acids: synthesis and solid-state structures of N-aryl anthranilic acid derivatives.
2006-01-06
A kinetically controlled trans bifunctionalized organoimido derivative of the Lindqvist-type hexamolybdate: synthesis, spectroscopic characterization, and crystal structure of (n-Bu4N)2{trans-[Mo6O17(NAr)2]} (Ar = 2,6-dimethylphenyl).
2005-12-26
Primary amido substituted diborane4 compounds and imidodiborate4 anions.
2005-10-07
Determination of local anaesthetics and their impurities in pharmaceutical preparations using HPLC method with amperometric detection.
2005-04-29
Synthesis, structure and pharmacology of acyl-2,6-xylidines.
2004-10-16
Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
2004-10-06
Metabolic activation of 2,6-xylidine in the nasal olfactory mucosa and the mucosa of the upper alimentary and respiratory tracts in rats.
2004-10
Liquid phase overtone spectral investigations of 2,6-dimethylaniline and 2,4-dimethylaniline-evidence for steric nature of the ortho effect and the consequent base weakening.
2004-08
Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis.
2004-04-01
Update on olfactory mucosal metabolic enzymes: age-related changes and N-acetyltransferase activities.
2004
Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes.
2003-10
An update of the National Toxicology Program database on nasal carcinogens.
1997-10-31
Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure.
1993-07
Hepatic effects of xylidine isomers in rats.
1979-01
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:30:45 GMT 2025
Edited
by admin
on Mon Mar 31 19:30:45 GMT 2025
Record UNII
695APM3L5Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2,6-XYLIDINE HYDROCHLORIDE
Systematic Name English
ROPIVACAINE RELATED COMPOUND A
USP   USP-RS  
Preferred Name English
ROPIVACAINE RELATED COMPOUND A [USP-RS]
Common Name English
BENZENAMINE, 2,6-DIMETHYL-, HYDROCHLORIDE (1:1)
Systematic Name English
LIDOCAINE HYDROCHLORIDE RELATED COMPOUND 2,6-DIMETHYLANILINE HYDROCHLORIDE [USP IMPURITY]
Common Name English
2,6-DIMETHYLANILINE HYDROCHLORIDE
Systematic Name English
BENZENAMINE, 2,6-DIMETHYL-, HYDROCHLORIDE
Systematic Name English
ROPIVACAINE RELATED COMPOUND A [USP IMPURITY]
Common Name English
2,6-XYLIDINE, HYDROCHLORIDE
Systematic Name English
2,6-DIMETHYLBENZENAMINE HYDROCHLORIDE
Systematic Name English
Code System Code Type Description
CAS
21436-98-6
Created by admin on Mon Mar 31 19:30:45 GMT 2025 , Edited by admin on Mon Mar 31 19:30:45 GMT 2025
PRIMARY
EPA CompTox
DTXSID80175705
Created by admin on Mon Mar 31 19:30:45 GMT 2025 , Edited by admin on Mon Mar 31 19:30:45 GMT 2025
PRIMARY
RS_ITEM_NUM
1605512
Created by admin on Mon Mar 31 19:30:45 GMT 2025 , Edited by admin on Mon Mar 31 19:30:45 GMT 2025
PRIMARY
PUBCHEM
88899
Created by admin on Mon Mar 31 19:30:45 GMT 2025 , Edited by admin on Mon Mar 31 19:30:45 GMT 2025
PRIMARY
ECHA (EC/EINECS)
244-388-1
Created by admin on Mon Mar 31 19:30:45 GMT 2025 , Edited by admin on Mon Mar 31 19:30:45 GMT 2025
PRIMARY
FDA UNII
695APM3L5Y
Created by admin on Mon Mar 31 19:30:45 GMT 2025 , Edited by admin on Mon Mar 31 19:30:45 GMT 2025
PRIMARY
MESH
C007766
Created by admin on Mon Mar 31 19:30:45 GMT 2025 , Edited by admin on Mon Mar 31 19:30:45 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE